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SUMMARY
Although TGFb is a potent inhibitor of proliferation, epithelia lacking the essential receptor (TbRII)
for TGFb signaling display normal tissue homeostasis. By studying asymptomatic TbRII-deficient
stratified epithelia, we show that tissue homeostasis is maintained by balancing hyperproliferation
with elevated apoptosis. Moreover, rectal and genital epithelia, which are naturally proliferative,
develop spontaneous squamous cell carcinomas with age when TbRII is absent. This progression
is associated with a reduction in apoptosis and can be accelerated in phenotypically normal epider-
mis by oncogenic mutations in Ras. We show that TbRII deficiency leads to enhanced keratinocyte
motility and integrin-FAK-Src signaling. Together, these mechanisms provide a molecular framework
to account for many of the characteristics of TbRII-deficient invasive SQCCs.INTRODUCTION
The development of cancers depends on the ability of tu-
mor cells to enhance growth-promoting programs and re-
strict growth-inhibiting mechanisms and apoptotic cell
death. This endows tumors with the advantage to over-
come growth limitations, which they accomplish by ac-
quiring multiple mutations in oncogenes and tumor sup-
pressor genes. Featured prominently in cancers are
oncogenic mutations that elevate Ras-MAPK signaling
to enhance the growth potential of cells. Yet the activation
of growth-promoting factors alone is not sufficient to sus-
tain tumorigenesis, which requires additional mutations to
abrogate growth-inhibiting factors. Retinoblastoma (Rb),
which sequesters the E2F transcription factor to arrest
cell cycle progression, is also frequently mutated in can-
cers. Together, Ras and Rb pathways represent the core
program controlling tissue homeostasis and their activities
are finely tuned by a variety of signaling mechanisms.CaThese nodes of interaction between peripheral signaling
pathways and the core machinery enable a diverse set
of oncogenes and tumor suppressor genes to hijack the
tissue homeostasis program and endow the mutated cells
with a growth advantage which eventually promotes tu-
morigenesis. Understanding these complex mechanisms
involving cell autonomous as well as nonautonomous
effects holds the promise of therapeutic approaches to
counteract tumorigenesis.
Under normal circumstances, the transforming growth
factor beta (TGFb) signaling pathway restricts tumorigen-
esis, particularly in epithelial tissues (Bierie and Moses,
2006; Massague and Gomis, 2006). TGFbs bind to a bidi-
meric surface receptor complex composed of receptor
types I (TbRI) and II (TbRII) to phosphorylate and activate
receptor-bound Smad (Smad2/3) transcription factors en-
abling them to translocate into the nucleus and regulate
TGFb-responsive genes. In cultured epithelial cells in vitro,
TGFbs act as potent inhibitors of proliferation. They act bySIGNIFICANCE
By generating a mouse model where an essential receptor (TbRII) for TGFb signaling is lost in stratified epithelia,
we’ve discovered an unexpected and specific link between spontaneous anogenital cancers and TbRII deficiency
in mice and in humans. We show that the transition from phenotypically normal homeostasis to tumor progression
is associated with a reduction in apoptosis, which unmasks hyperproliferative and migratory defects also caused
by TbRII deficiency. Finally, progression to carcinogenesis in TbRII-deficient stratified epithelial tissues is accel-
erated upon oncogenic mutations or otherwise sustained signaling of the Ras/MAPK pathway. These findings
provide insights into our understanding of squamous cell carcinomas, which are among the most prevalent and
life-threatening cancers in the world.ncer Cell 12, 313–327, October 2007 ª2007 Elsevier Inc. 313
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p15Ink4B and p21Cip to prevent Rb inactivation, resulting
in a concomitant downregulation of c-Myc expression
(Iavarone and Massague, 1997; Pietenpol et al., 1990;
Reynisdottir et al., 1995). Thus, TGFb signaling shows
tumor suppressor characteristics, and TbRII is frequently
mutated or transcriptionally suppressed, in human epithe-
lial tumors.
Given the ascribed effects of TGFb signaling on growth
inhibition, it is surprising that many epithelia—including
mammary gland, oral mucosa, esophagus, pancreas
and intestine—still develop normally upon quantitative
ablation of TGFb signaling through conditional targeting
of the TbRII gene (Biswas et al., 2004; Forrester et al.,
2005; Ijichi et al., 2006; Lu et al., 2006; Munoz et al.,
2006). That said, progression to cancers occurs rapidly
when the TbRII null epithelial tissues are exposed to acti-
vated oncogenes (often oncogenic Ha-Ras) and/or loss of
additional tumor suppressors, suggesting that some as
yet unidentified feature of the homeostasis balancing
mechanism must be compromised in the absence of
TGFb signaling. Another intriguing twist is the appearance
of spontaneous invasive squamous cell carcinomas
(SQCCs) of the forestomach epithelium that arises non-
cell autonomously from ablation of TbRII in stromal fibro-
blasts (Bhowmick et al., 2004).
Analysis of the function of TGFb signaling in surface ep-
ithelia has thus far been limited to dominant negative and
overexpression strategies. Perhaps not surprisingly, re-
sults have often been conflicting, and both positive and
negative effects on normal epidermal homeostasis and
wound healing have been described (Amendt et al.,
1998; 2002; Crowe et al., 2000; Ito et al., 2001; Wang
et al., 1997b). In addition, despite TGFb’s well-docu-
mented function as a suppressor of proliferation in cul-
tured keratinocytes, skin tumorigenesis is paradoxically
promoted when carcinogenesis protocols are applied to
transgenic mice that either display superactivated TGFb
signaling (through overexpression of TGFbs) or sup-
pressed TGFb signaling (through overexpression of dom-
inant negative TbRII) (Amendt et al., 1998; Cui et al., 1996;
Cui et al., 1995; Go et al., 2000; Han et al., 2005; Wang
et al., 1997b; Wang et al., 1999; Weeks et al., 2001).
Some of these disparate results are likely to arise from
combinatorial extrinsic and intrinsic effects, sincebothder-
mal and epidermal cells respond to TGFbs. Additionally,
some studies suggest that TGFbs act as growth suppres-
sors early but act as metastasis promoters later in tumor
progression (Bierie and Moses, 2006). To this end, both
gain and loss of TGFb signaling have been reported to pro-
mote invasive cell migration (Bhowmick et al., 2001; Ozda-
mar et al., 2005; Wang et al., 2005) as well as apoptosis
(Amendt et al., 2002; Forrester et al., 2005), depending on
cellular context and stage of tumorigenesis. Overall, these
data suggest that the cell’s signaling profile may define
the functional consequences of TGFb signaling.
In the current study, we use a keratin 14 (K14) promoter,
active in surface, oral, and anogenital stratified squamous
epithelia as well as some glandular and ductal epithelia314 Cancer Cell 12, 313–327, October 2007 ª2007 Elsevier Inc(Wang et al., 1997a) to conditionally target the loss of TbRII
in mice. We show that mice lacking TGFb receptor signal-
ing in K14-positive cells develop spontaneous invasive
SQCCs in their anal and genital epithelia, and that TGFb
signaling is diminished in human genital SQCCs. By con-
trast, TbRII null epidermis is phenotypically normal, and
although wounds heal faster, oncogenic transformation
with Ha-Ras is required to promote invasive SQCC and
metastasis. Exploiting the ability to culture primary epider-
mal keratinocytes from our mice, we employ a combina-
tion of in vitro and in vivo strategies to explore the intrinsic
and extrinsic mechanisms underlying how asymptomatic
TbRII null stratified epithelia are able to maintain homeo-
stasis, how they lose it, and why this happens at a higher
frequency in anogenital epithelium. We also investigate
how elevated Ras-MAPK signaling accelerates an imbal-
ance in homeostasis and progression to SQCC when
TGFb signaling is defective. Finally, we address why loss
of TbRII leads to enhanced cell motility and provide
insights as to how this may promote invasive metastatic
SQCCs and accelerated wound healing in epithelial
tissues.
RESULTS
Conditional Targeting of the TGFb Receptor II
Gene in Mice Results in Spontaneous Anal
and Genital SQCCs with Age
Mice harboring the TbRII floxed exon 4 (Leveen et al.,
2002) were bred to mice expressing Cre recombinase
under the control of the human K14 promoter, strongly
active by embryonic day 15 (E15) in proliferative cells of
most surface stratified squamous and glandular epithelia,
as well as oral, anal, and genital stratified squamous epi-
thelia (Vasioukhin et al., 1999) (Figure S1A in the Supple-
mental Data available with this article online). K14-Cre/
TbRII(fl/fl) conditional knockout (cKO) mice were viable
and appeared phenotypically normal through early adult-
hood. As judged by real-time PCR, in situ hybridization,
and immunoblot analyses, intact TbRIImRNA and protein
were absent by postnatal day 2 (P2) in skin epithelium and
in cultured primary keratinocytes (MKs) derived from
neonatal backskin epidermis (Figure 1A, and Figures
S1A–S1D).
Adult TbRII cKO mice developed SQCCs in their anal
and genital regions, starting as early as 4 months of age
(Figure 1B). By 7 months, 89% of cKOmice displayed vis-
ible signs of tumor formation (Figure 1C). Histological
analyses revealed SQCCs arising within the anal canal in
a transitional zone between stratified squamous epithe-
lium of anal skin andmucosal epithelium of the large intes-
tine. Typified by keratinized cells, the SQCCs infiltrated
surrounding stroma and tunica muscularis of the rectum
(Figure 1D). In males, genital SQCCs arose from prepu-
tial ductal epithelium and invaded surrounding stroma
(Figure S2A). In females, SQCC tumors developed from
mucosal stratified squamous epithelium of vagina and
rectum and from adjacent follicular/adnexal epithelium
(Figure S2B)..
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Loss of TGFbRII in Stratified EpitheliaFigure 1. Adult TbRII cKO Mice Develop Spontaneous Anogenital SQCCs
(A) Efficient targeting and loss of TbRII mRNA was assessed by real-time PCR using primer pairs corresponding to the floxed exon 4 of TbRII.
MK, primary keratinocytes. Mean ± SD.
(B) Anal and vaginal tumors were visible in 6-month-old cKO, but not WT mice.
(C) Kaplan-Meier curves depicting the probability of tumor-free survival with age. M, male; F, female. Note that >89% of cKO mice developed
anogenital tumors within 7 months, while WT and heterozygous (Het) animals were tumor-free.
(D) Hematoxylin- and eosin-stained longitudinal sections of the distal colon, rectal, and anal/perianal tissues revealed classical SQCC pathology in
7-month-old cKO, but not in WTmice. SQCCs displayed anastomosing trabeculae and nests of keratinized squamous cells organized around central
cavities, and were associated with moderate, multifocal, and chronic lymphoplasmacytic inflammation around the tumor masses.Immunostaining of anal and genital SQCCs confirmed
the loss of TbRII protein and phosphorylated (active)
p-Smad2 in these keratin 14 (K14) and keratin 5 (K5)-pos-
itive tumors (Figures S3 and S4). By contrast, the TbRII-
positive stromal tissue surrounding the tumors exhibited
p-Smad2, indicative of TGFb signaling, and also infiltration
of smooth muscle actin-positive myofibroblasts. Similar
changes were observed in the stroma surrounding spon-
taneous genital SQCCs.
Human Genital SQCCs Exhibit Diminished
TbRII Signaling
Given that TbRII function seemed to suppress develop-
ment of spontaneous anogenital tumors in mice, we won-
dered whether TGFb signaling might also be affected in
human genital cancers. As judged by immunohistochem-
istry, TbRII was reduced or absent in 73% of the 80 male
genital SQCC samples tested (Figures 2A and 2B). Con-
comitant with this reduction was a corresponding loss of
activated Smad2within the tumor tissue, despite the pres-
ence of TGFb1 ligand (Figures 2A and 2B) Similarly, 76%
(n = 41) of female genital SQCCs displayed reduced or
absent TbRII protein which correlated with reduced orCaabsent p-Smad2 (Figures 2C and 2D). Interestingly, these
features were even observed in early-stage grade I genital
tumors of both sexes, suggesting that loss of TbRII signal-
ing may be an early event in tumor progression.
In K14-TbRII Null Animals, Spontaneous SQCCs
Develop at Transitional Zones between Two
Merging Epithelial Tissue Types
It was notable that the spontaneous SQCCs arising in our
TbRII cKO mice frequently arose within transitional zones
between two merging but distinct epithelial tissue types.
Tumor susceptibility was especially prominent at the
juncture of K5/K14-positive mucosal stratified squamous
epithelium of the anal canal and K8/K18-positive simple
epithelial tissue of the large intestine. Interestingly, irre-
spective of the status of TbRII gene targeting, anal canal
epithelium at this juncture displayed many features typi-
cally associated with hyperproliferative epidermis (Scha¨-
fer and Werner, 2007). This included expression of both
suprabasal markers, e.g., keratin 17 (K17) and keratin 6
(K6), and basal markers, e.g., b6-integrin (b6) and Tenas-
cin C (TnC) (Figure 3A and Figure S5). Further reflective
of an atypical hyperproliferative epidermal state was thencer Cell 12, 313–327, October 2007 ª2007 Elsevier Inc. 315
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Male (B) and female (D) human genital SQCCs were scored according to their grade of severity (I-lowest to III-highest) and analyzed for TbRII, phos-
phorylated (activated) Smad2, TGFb1 and/or K14 by immunohistochemistry (IHC). Examples of IHC staining from amale genital SQCC grade I (A) and
from a female SQCC grade II (C) show reduced or no anti-TbRII, in contrast to perilesional, matched control skins. TbRII loss correlated with a lack of
p-Smad2 staining in 10 out of 10 SQCC samples. TGFb1 and K14 served as internal quality controls and were detected in TbRII-deficient human
samples. Scoring: (+), positive staining; (), negative staining; (low), reduced expression. Epi, epidermis; Der, dermis; Str, stroma. Lines encircle
SQCCs in the top panels.presence of a large number of macrophages (Mac1) within
the underlying anogenital stroma (Figures 3Ba and 3Bb).
Overall, the natural state of anogenital transitional epi-
thelium more closely resembled that of backskin epider-
mis when subjected to an imbalance in tissue homeo-
stasis due to injury, microbial infection, inflammation, or
precancerous lesions (Coulombe, 2003; Weiss et al.,
1984).
Control of Epithelial Homeostasis in the Absence
of TbRII Relies Upon the Ability to Balance
Offsetting Increases in Proliferation
and Apoptosis
Tissue homeostasis depends on a balance between pro-
liferation, differentiation, and apoptosis, and aberrations
in this equilibrium can result in the development of tumors.
To test whether tissue homeostasis was affected in the
anogenital tissue of asymptomatic cKO mice we pulsed
these animals for 48 hours with BrdU and analyzed the
level of proliferation. We detected a significant increase
in the number of S phase cells within the epithelia of
both anal canal and anal skin of 7 week cKO animals
when compared to their wild-type (WT) littermates (Fig-
ure 3Cb). As mice aged, BrdU incorporation waned in316 Cancer Cell 12, 313–327, October 2007 ª2007 Elsevier Inc.anal epithelium of WT mice and in asymptomatic cKO
epithelium, but it remained high in spontaneous tumors
(Figure 3Cb).
Whether WT or cKO, wherever homeostasis was main-
tained, BrdU-positive epithelial cells were largely confined
to a single epithelial layer adjacent to the basement
membrane (Figure 3Ca). By contrast, proliferation often
extended to suprabasal layers in the anal canal of 7-
month-old cKO mice. Elevated proliferation was also
noted in underlying stroma, further reflective ofmesenchy-
mal-epithelial interactions (Figures 3Ca and 3Cb). Consis-
tent with the marked hyperproliferation, anal canal epithe-
lium displayed signs of elevated Ras-MAPK signaling
(Figures 3Da, 3Db, and 3E). Antibodies against p-MAPK
(Erk1, Erk2) and pan-Ras both stained the tumor more
strongly than adjacent or asymptomatic tissues. Thus,
the increase inRas-MAPKsignaling correlatedwith tumor-
igenesis and a loss of homeostasis in TbRII-deficient anal
epithelium.
Tissue homeostasis can be maintained in a hyperproli-
ferative tissue either by increased cell death or acceler-
ated differentiation. To test whether the hyperproliferation
seen in asymptomatic anal epithelium of cKO mice might
be counterbalanced by an increase in apoptosis, we
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activated caspase 3 (Ac-casp3). At 7 weeks of age, while
apoptotic cells were rare in WT, they were frequent within
the basal layer of cKO anal epithelium (Figures 3Fa and
3Fb). By 7 months of age, however, when anal tumorigen-
esis was common in cKO mice, the numbers of apoptotic
cells were low in both WT and cKO anal epithelia.
Taken together, these findings suggest that when TbRII
is deficient in anal epithelium of younger mice, homeosta-
sis is still maintained by balancing enhanced proliferation
with apoptosis; however, as animals age, the spontane-
ous transition to tumorigenesis is accompanied by a de-
cline in apoptosis, tipping this equilibrium between prolif-
eration and cell death.
Malignant Conversion of Ha-Ras-Induced
Papillomas to SQCCs in Backskin Lacking TbRII
Given our findings with anal epithelia, we wondered
whether the counterbalancing of elevated proliferation
and apoptosis might also account for why loss of TbRII
did not overtly seem to affect backskin epidermis and its
appendages. We analyzed proliferation and apoptosis
levels in two different stem cell compartments of skin
epithelium: the slow cycling a6 integrin-positive, CD34-
positive cells from the hair follicle bulge (Morris et al.,
2004) and the more proliferative a6 integrin-positive,
CD34-negative cells from the basal layer of interfollicular
epidermis. Following a 48 hour pulse of BrdU adminis-
tered to 7-week-old mice, fluorescence-activated cell
sorting (FACS) was used to analyze the two populations
from skin.
Despite signs of elevated TGFb signaling normally dis-
played by bulge stem cells (Figure S7A) (Tumbar et al.,
2004), the loss of TbRII did not appear to alter their quies-
cent state nor affect apoptosis (Figure 4A). By contrast,
basal interfollicular epidermal cells exhibited an 23 in-
crease in BrdU incorporation within 48 hours, which was
counterbalanced by elevated apoptosis (Figure 4A). Al-
though perturbations in proliferation and apoptosis were
lower in cKO backskin epidermis than in cKO anogenital
epithelium, the outcome was similar, namely, a morpho-
logically normal epithelium. In contrast to anogenital
epithelium, however, epidermal homeostasis was main-
tained as animals aged.
Since Ras-MAPK activity was strongly enhanced in
TbRII-deficient anogenital tumors, we wondered whether
oncogenic mutations in this pathway might tilt tissue
homeostasis in TbRII-deficient epidermis to promote
SQCC formation. To test this hypothesis, we briefly cul-
tured freshly isolated epidermal cells from WT and cKO
mice, infected them with a retroviral vector expressing
an oncogenic mutation in the GTPase domain of Ha-Ras
(Ha-RasV12), and grafted these cells onto backs of athy-
mic Nude mice (Figure 4B; Figures S6A and S6B). By
4 weeks, control grafts from Ha-Ras infected WT epider-
mal cells displayed visible and morphological signs of
benign papilloma expected from Ha-Ras transformation
of skin (Bailleul et al., 1990) (Figures 4C and 4D, and
Figure S6C). Notably, TbRII expression was maintainedCin these papillomas, as judged by immunohistochemistry
(Figure S6E).
In striking contrast, grafts from Ha-Ras-infected KO
MKs displayed overt aberrations soon after grafting
(Figure S6D). By 4 weeks, 100% of cKO-Ras grafts had
developed large, aggressive tumors, which often devel-
oped signs of ulcerations and necroses in the tumor cen-
ter (Figure 4C). Ethical concerns mandated sacrificing
mice within 4 weeks, at which time the cKO-Ras engrafted
skin displayed signs of poorly differentiated SQCCs, in-
cluding cellular atypia, mitoses, cellular disorganization,
and invasion (Figure 4D). At the ultrastructural level, an in-
tact basal lamina demarcated the dermal-epidermal
boundary in normal skin of the Nude mouse (Figure 4E,
left frame), while in invasive, Ha-Ras transformed TbRII
null SQCCs, it was discontinuous and often absent
(Figure 4E, right frame).
Both Ha-Ras papillomas and TbRII null/Ha-Ras SQCCs
displayed elevated BrdU incorporation relative to WT
backskin (compare Figures 4F and 4A). While BrdU-posi-
tive cells were confined to the basal and first few supra-
basal layers of papillomas, they were dispersed through-
out the TbRII null/Ha-Ras SQCCs (Figure S6G). Outside
necrotic regions, 2.53 more BrdU-positive cells were
found in the TbRII null/Ha-Ras SQCCs when compared
to Ha-Ras papillomas (Figure 4F), while apoptoses were
comparable and low compared to Ha-Ras papillomas
(Figures S6H, Figure 4F).
To determine whether alterations in epithelial prolifera-
tion in TbRII null cells are cell-intrinsic or dependent
upon their environment, we examined KO MKs in vitro.
In contrast to their WT counterparts, these cells were
refractory to TGFb signaling and displayed no signs of
activated phospho-Smad2 when exposed to recombinant
active TGFb1 or TGFb2 (Figure 4G). KO MKs also failed to
undergo TGFb-mediated growth arrest (Figure 4H), and
did not accumulate in the G0/G1 phase of the cell cycle
at the expense of S phase cells (Figure 4I and Fig-
ure S7B). Similarly, only WT MKs responded to TGFb1
by enhanced expression of cyclin-dependent kinase
inhibitors p15INK4b and p27Kip1 (Figure S7C). Thus,
although KO and WT MK were comparably hyperprolifer-
ative in the absence of TGFb signaling, marked differ-
ences were noted when TGFbs were present. Notably,
p-Smad2 and TGFb1 were both upregulated in the stroma
surrounding Ha-Ras cKO SQCCs (Figure S6F).
To test whether differences in apoptosis are intrinsic to
the loss of TbRII function, we treated MKs with TGFb1
(test) or the potent apoptosis-inducer TNFa (control),
and used FACS to quantify expression of the apoptosis
marker Annexin V. Even after treating with TGFb1 for
72 hours, apoptosis levels remained low, and no signifi-
cant differences were noted between WT and KO MKs
(Figure 4J, blue and red bars, respectively). We next
examined the ability of Ha-Ras transformation to impact
apoptosis. Even without exogenously added TGFb1, Ha-
Ras MKs exhibited an 2.53 increase in apoptosis, and
when TGFb1 was added, this level rose another 23. In
striking contrast, apoptosis levels remained low in theancer Cell 12, 313–327, October 2007 ª2007 Elsevier Inc. 317
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Loss of TGFbRII in Stratified EpitheliaFigure 3. Tissue Homeostasis Is Impaired in the Anal Canal of Older TbRII cKO Mice
(A) The anal canal epithelium is a transitional epithelium bordering stratified squamous epithelium of anal skin and simple epithelium of large intestine.
Immunofluorescence microscopy of frozen tissue sections revealed that this epithelium naturally expresses many markers of a hyperproliferative318 Cancer Cell 12, 313–327, October 2007 ª2007 Elsevier Inc.
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Loss of TGFbRII in Stratified EpitheliaTbRII null/Ha-RasMKs (Figure 4J). Thus, the loss of TbRII
appeared to renderHa-Ras transformedMKs refractory to
TGFb1-mediated apoptosis.
The similarities in Ha-Ras transformed epidermis and
WT anal epithelium to loss of TbRII prompted us to exam-
ine the status of the molecular markers that we previously
found to distinguish the anal canal from backskin of WT
mice. Ha-Ras-induced papillomas expressed K17, K6,
and TnC, and caused a marked macrophage infiltration
in underlying dermis (Figure 4K, left). These alterations
were as ormore pronounced in TbRII null/Ha-Ras-induced
SQCCs, and in addition, b6-integrin was selectively found
at invasive fronts (Figure 4K, right).
Taken together, these data suggest that loss of TbRII in
epidermal keratinocytes cooperateswith oncogenicmuta-
tions inHa-Ras to promote hyperproliferation andmaintain
low levels of apoptosis, resulting in a gross imbalance in
tissue homeostasis, which progresses to SQCC. Ha-Ras
transformation of epidermis also induced features of WT
anogenital epithelium, and although the initiating event
remains to be uncovered, Ras-MAPK signaling was
elevated in spontaneous anogenital tumors that formed
in older TbRII cKO mice. These findings may account for
differences in susceptibility of TbRII-deficient anogenital
and backskin epithelium to homeostatic imbalancing and
tumor progression.
Elevated Integrin and FAK Activity Is Intrinsic
to the Loss of TbRII in Stratified Epithelia
The increased susceptibility of TbRII null epidermis to Ha-
Ras induced SQCC formation was further tested by treat-
ing mice with the chemical mutagen 7,12-dimethyl-benz
[a] anthracene (DMBA), which typically induces mutations
in Ha-Ras (Balmain et al., 1984) but requires additional
promoting agents to generate SQCCs (Yuspa et al.,
1995). In contrast toWTmice, cKOmice developed visible
backskin tumors within 5–6 weeks following DMBA treat-
ments (Figure 5A). After 15–20 weeks, cKO mice had an
average of 7 tumors each, and pathological analyses
revealed signs of K14-positive SQCCs in the lungs, sug-
gestive of metastases (Figure 5B).
Elevated focal adhesion kinase (FAK) has been de-
tected in head and neck SQCCs (Canel et al., 2006), and
mice lacking epidermal FAK are more resistant to
DMBA/TPA-induced SQCCs (McLean et al., 2004). To de-
termine whether FAK expression and/or activation might
be involved in SQCCs formed in TbRII cKO animals, we
first conducted immunohistochemistry. Whereas anti-Cbodies against FAK only weakly labeled WT tissue, stain-
ing was readily detected in cKO anal epithelium (Figures
5C and 5D). Signs of activated (pY397) FAK were even
more pronounced in the SQCCs that formed (Figures 5E
and 5F). Elevated FAK activity was observed in both basal
and suprabasal layers, consistent with the atypical supra-
basal expression of integrins known to occur in SQCCs
(Owens and Watt, 2001).
To better assess the relationship between loss of TbRII
and elevated FAK activity, we next plated MKs on fibro-
nectin (FN)-coated dishes and cultured them in absence
or presence of serum. Immunoblot analyses of protein
extracts revealed that in vitro as in vivo, KOMKs displayed
elevated FAK activity (Figure 5G). Using analogous phos-
phospecific antibodies, we found that Src and MAPK
activities, but not the cell survival kinase AKT, were ele-
vated in TbRII null MKs compared to WT MKs (Figures
5H and 5I and data not shown). FAK, Src, and MAPK
activities were enhanced even in serum-free media (Fig-
ures 5G–5I), suggesting that signaling through integrins
and cell matrix interactions might be responsible for these
differences. We tested this hypothesis by analyzing the
in vivo expression and activity of b1-integrin, a key activa-
tor of FAK. In adult cKO backskin, anti-b1-integrin labeled
the basal epidermal layer as well as the dermis, while an-
tibodies against the activated form of b1-integrin only
showed strong labeling in the dermis (Figure 5J). By con-
trast, both antibodies labeled the cKO anal canal promi-
nently, in stroma and in SQCC cells (Figures 5K and 5L).
TbRII null/Ha-Ras SQCC cells also exhibited enhanced
b1-integrin signaling (Figure 5M). The association of in-
creased b1-integrin activation with TbRII-ablation was
also observed in vitro, where we could use FACS analysis
to quantify surface integrin levels (Figure 5N).
TbRII-Deficient Epidermal Keratinocytes Possess
a Cell-Autonomous, Enhanced Ability to Migrate,
Degrade Extracellular Matrix, and Invade: In Vivo
and In Vitro Studies
The data presented in Figure 5 suggest that loss of TbRII
might enhance keratinocyte migration through activation
of integrin-FAK-Src signaling. To explore this possibility
further, we next monitored the response of our mice to
4 mm punch biopsy wounds. Interestingly, cKO wounds
healed faster (Figure 6A). FAK and MAPK were hyperacti-
vated at the wound edge in both WT and cKO skins,
although the wound edge was noticeably thicker in cKO
skin (Figures 6B and 6C). BrdU labeling substantiatedstate, including K17, K6, b6-integrin (b6), and tenascin C (TnC). b4-integrin (b4) or K5 label the basal-like cells of the anal canal. Epithelial-stromal
border is denoted by white lines. DAPI (blue) labels nuclear chromatin. Str, stroma.
(B) (Ba) Inflammatory Macrophages (Mac1) are prevalent in the stroma underlying the anal epithelium. (Bb) Mac1-positive cells are much more prev-
alent in the anal region (Anal) than in backskin epidermis (Epi) in both WT and cKO mice.
(C–F) TbRII null anal epithelium exhibits sustained hyperproliferation but maintains homeostasis through enhanced apoptosis, which is lost in spon-
taneous tumors.
(Ca–E) Proliferation was assayed by BrdU incorporation and correlates with pronounced Ras/p-MAPK staining. (Fa) Apoptosis was assayed by
immunostaining for activated caspase 3 (Ac-casp3) (arrows). (Cb, Db, and Fb) Quantification of proliferation and apoptosis in WT and cKO anal canal
and adjacent anal epidermis at 7 weeks when the cKO anal canal is histologically normal, and 7 months when it appears hyperplastic. Accelerated
proliferation is balanced by increased apoptosis when homeostasis is maintained, while alleviated apoptosis correlated with tumor formation. Graphs
represent the mean (±SD) of 3 different WT and cKO mice. *p < 0.05.ancer Cell 12, 313–327, October 2007 ª2007 Elsevier Inc. 319
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Loss of TGFbRII in Stratified EpitheliaFigure 4. TGFb and Ras-MAPK Signaling Also Cooperate to Control Tissue Homeostasis in the Epidermis
(A) Proliferation and apoptosis rates are increased in the stem cell compartment (basal layer) of TbRII null epidermis (Epi) (a6+CD34), but not in the
stem cell compartment (bulge) of the hair follicle (a6+CD34+). Analyses were performed on adult mice (7 wk). Graphs represent the mean (±SD) of 3
different WT and cKO mice. *p < 0.05.
(B) Schematic of tumor susceptibility assay where primary keratinocytes (MKs) fromWT or cKO backskins were isolated, infected with a retrovirus ex-
pressing constitutively active (oncogenic) Ha-Ras, and grafted together with WT dermal fibroblasts (DF) onto the backs of Nudemice. HF, Hair follicle.
(C) At 23 d, papillomas formed from Ha-RasMKs, while invasive SQCCs formed from TbRII null/Ha-RasMKs. Note necrosis in center of large tumor.
(D) Hematoxylin- and eosin-stained tissue sections revealed papilloma (Pap) pathology in Ha-Ras graft and SQCC pathology in TbRII null/Ha-Ras
graft.
(E) Ultrastructural analysis indicated a compromised basal lamina underlying Ha-Ras transformed, TbRII null SQCCs (right frame). Scarcity of hemi-
desmosomes (Hd) and perturbed basal lamina (BL) is typical of invasive SQCCs. The basal lamina appeared uncompromised at the boundary
between Epi and dermis (Der) in adjacent nude skin (left frame).320 Cancer Cell 12, 313–327, October 2007 ª2007 Elsevier Inc.
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Loss of TGFbRII in Stratified Epitheliathe hyperproliferative status of cKO epidermis in the
wound area, and anti-Ac-casp 3 immunofluorescence
suggested that apoptosis was selectively reduced at the
wound site, thereby accounting for the corresponding
thickened tissue (Figures 6D and 6E). When tissue ex-
plants were transferred from backskin to FN-coated cul-
ture dishes, epidermal outgrowth was also accelerated
when TbRIIwas absent (frames in Figure 6F). These differ-
ences were striking when 5 ng/ml active TGFb1 was
added to the culture medium, a feature which abruptly
inhibited outgrowth from WT explants while leaving cKO
explants unaffected (graph in Figure 6F).
A priori, the enhanced wound healing and explant
outgrowth could be due solely to the imbalance in tissue
homeostasis caused by loss of TbRII. Alternatively, it
might reflect an additional migratory and/or invasive
advantage. To distinguish between these possibilities,
we conducted transwell migration assays in which pri-
mary MKs were placed in the upper compartment of
a Boyden chamber, while fibroblast-conditioned medium
was placed as a stimulus in the bottom chamber. In these
assays, KOMKs exhibited amigratory advantage overWT
cells with and without additional expression of Ha-Ras,
but Ha-Ras enhanced the effects (Figure 7A). When the
assay was repeated, this time after coating the chamber
filter with Matrigel (extracellular matrix), KOMKs exhibited
an increased ability to invade the matrix and traverse the
filter (Figure 7B). Again, the presence of oncogenic Ha-
Ras enhanced the invasive behavior both in KO and WT
cells. Moreover, since the stimulus used in the bottom
chamber was always the same, the observed differences
in migration and invasion must initiate from keratinocyte-
autonomous changes resulting from TbRII-deficiency
and/or elevated Ha-Ras activity, which appeared to act
synergistically.
We quantified cell velocities by imaging the migrations
of MKs on FN-coated slides (n = 30 over 12 hr). By video-
microscopy, the significantly faster velocities of KO MKs
were readily visualized (Figure 7C). Moreover, the acceler-
ated movement was directly due to the loss of TbRII, as
re-expression of TbRII restored p-Smad2 activity and res-
cued the cell motility advantage (Figures 7C and 7D). Fur-
thermore, although treatment of WT MKs with TGFb1
slightly accelerated their motility, they did not reach the
pace of KO cells, which were insensitive to TGFb1 treat-
ment (Figure 7E). Taken together, these findings under-Cascore the intrinsic importance of TbRII-deficiency in the
enhanced migratory behavior of MKs.
Finally, we treated MKs with the MEK1 inhibitor
PD98059 and the Src/FAK inhibitor PP2 to test the degree
towhich downstream elevation ofMAPK or FAK/Src activ-
ities might account for the differences in cell motility.
Although inhibition of MEK1 only modestly reduced motil-
ities, inhibition of Src/FAK had a more robust effect (Fig-
ures 7F and 7G). These findings suggest that the elevated
Src/FAK activities contribute to the enhanced migratory
behavior of TbRII cKO epithelia, which could be important
in their increased susceptibility to homeostatic imbalance
and tumorigenesis.
DISCUSSION
Balancing Hyperproliferation and Apoptosis
to Maintain Homeostasis
The development of spontaneous anogenital SQCC in our
TbRII cKOmice was unexpected. No significant patholog-
ical changes have been identified in internal stratified or
simple epithelia lacking TbRII expression (Biswas et al.,
2004; Ijichi et al., 2006; Lu et al., 2006), and while TbRII
null mammary epithelia exhibited a transient hyperplasia
in neonatal mice, this regressed during adulthood, and tis-
sue homeostasis was maintained thereafter (Forrester
et al., 2005). Similarly in our own studies, tissue homeosta-
sis was maintained in the absence of TbRII, and both in
backskin epidermis and in juvenile anogenital epithelium,
enhanced hyperproliferation was counterbalanced by an
increased apoptosis rate.
As cKOmice aged, apoptosis decreased significantly in
the anogenital epithelium, while cells remained hyperproli-
ferative and sustained elevated Ras-MAPK signaling. This
age-related imbalance in TbRII-deficient tissue homeosta-
sis correlated with the appearance of spontaneous ano-
genital SQCCs. Moreover, even though we did not detect
spontaneousSQCCs in cKObackskin, invasivemetastatic
SQCCs were readily induced by oncogenic mutations in
Ha-Ras or treatment with the mutagen DMBA.
Like the spontaneous anogenital tumors which formed,
Ha-Ras transformed cKO backskin tumors exhibited sig-
nificantly reduced apoptosis rates while simultaneously
remaining hyperproliferative. Our data on cultured MKs
revealed that TGFb signaling in cells transformed by onco-
genic Ha-Ras induces apoptosis in WT cells, and this(F) TbRII null/Ha-Ras-induced SQCCs exhibited sustained hyperproliferation without enhanced apoptosis. Graphs represent the mean (±SD) of 3
different WT and cKO mice. *p < 0.05.
(G) TbRII null MKs fail to activate Smad2 and remain resistant to a G1 growth arrest when stimulated with TGFbs as judged by growth curves and cell
cycle profiles.
(H and I) MKs were cultured in low Ca2+ medium in the presence or absence of 5 ng/ml TGFb1, added at day 2. Growth curves (H) indicate the
average value of 3 independent experiments performed in triplicate (±SD). (Note: by this assay and Elisas, active TGFbs are low/absent in epidermal
culture medium.) (I) Cell cycle analyses with propidium iodide staining.
(J) FACS analysis for the presence of the apoptotic marker annexin-V revealed that Ha-Ras and TGFb signaling cooperate to induce apoptosis in WT
MKs, while apoptosis rates remain low and unaltered in KO MKs under these conditions. TNFa (100 ng/ml) and cycloheximide (5 mg/ml) induced
apoptosis in WT MKs served as a positive control. Bar graphs indicate mean value (±SD) on duplicate experiments.
(K) Keratin 17 (K17), Tenascin C (Tnc), and b6-integrin are expressed in bothHa-Ras papillomas and TbRII null/Ha-Ras SQCCs. b4-integrin marks the
basal cell layer and Macrophages (Mac1) are recruited to the tumor stroma. Note similarities between the expression patterns in Ha-Ras papillomas
(here) and WT anogenital epithelia (Figure 3).ncer Cell 12, 313–327, October 2007 ª2007 Elsevier Inc. 321
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Loss of TGFbRII in Stratified EpitheliaFigure 6. Wound Closure Is Accelerated in cKO versus WT Animals
(A) Shown are representative examples at 0, 3, and 7 days after wounding.
(B and C) Immunohistochemistry reveals activated FAK and MAPK at the epidermal wound edge by day 3 after wounding. Note hyperthickening of
wounded cKO skin. Epi, epidermis; Der, dermis.
(D and E) Quantification of proliferation and apoptosis inside and outside the wound area. Bar graphs depict mean ± SD. *p < 0.05.
(F) WT and cKO skin explant outgrowth in serum-containing media indicate accelerated epidermal outgrowth from cKO skin explants, a difference
that becomes even more pronounced upon addition of active TGFb (5 ng/ml) to the culture medium on day 2. Graph indicates the mean value of three
independent experiments (±SD). *p < 0.03. Phase contrast images show extent of outgrowth at 4 days in the absence of active TGFb.effect is quantitatively lost when TbRII is mutated. Taken
together, these findings suggest that loss of TbRII signal-
ing stresses the homeostatic circuitry of stratified squa-Cmous epithelia by uncoupling the ability of keratinocytes
to execute apoptosis in the face of oncogenic mutations
that promote a sustained hyperproliferative state.Figure 5. Invasive Metastatic Skin Tumors Correlate with Increased Integrin, FAK, Src, and MAPK Activities
(A) DMBA treatment of mice revealed a marked increase in DMBA-induced tumor formation in the absence of TbRII.
(B) Lung metastasis from TbRII-cKO mouse topically treated with DMBA to induce backskin SQCCs. Note typical keratinized SQCC histology as
revealed by hematoxylin and eosin staining and K14 immunohistochemistry.
(C–F) Anti-FAK and p-FAK immunohistochemistry on sections fromWT anal canal (C), cKOpretumor and tumor stage of anogenital skin (D and E), and
cKO-Ras backskin SQCC (F). Str, stroma; Epi, epidermis; Der, dermis.
(G–I) Immunoblots of protein lysates from MKs grown in the presence or absence of serum, ±4 min serum stimulation where indicated. Note: Src
activity was assessed by immunoprecipitation/immunoblot analysis using Src and pY417-Src antibodies.
(J–M) Immunofluorescence with antibodies against b1- and active b1-integrin (Ac-b1) performed on tissue sections as indicated.
(N) Quantitative FACS analysis of KO (red) versusWT (blue) culturedMKswith antibodies against the cell surface integrins indicated. Gray lines depict
secondary antibody-only control.ancer Cell 12, 313–327, October 2007 ª2007 Elsevier Inc. 323
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Loss of TGFbRII in Stratified EpitheliaFigure 7. Elevated Cell Motility in the Absence of TbRII
(A and B) Elevated cell motility in the absence of TbRII. Transwell migration assays were carried out on Boyden chambers ± coating withMatrigel ECM
on the top chamber and in the absence and presence of fibroblast-conditioned medium, used as stimulus in the bottom chamber. Bar graphs depict
means of 3 independent experiments ± SD. *p < 0.03. **p < 0.004. Note that KO MKs showed elevated migration and invasion over WT MKs, and
Ha-Ras transformation enhanced these effects.
(C and D) Rescue experiment to show that the enhanced migratory ability of KOMKs is specifically attributable to TbRII loss. The CMV promoter was
used to drive TbRII cDNA, which restored cell velocities to WT levels (C). Immunoblot shows that re-expression of TbRII in KO MKs restores TGFb2
responsiveness (D).
(E) TGFb1 treatment has only a slight effect on the velocity of WT MKs, which are still significantly less motile than KO MKs.
(F and G) Enhanced MAPK (Erk) and Src/FAK activities promote cell motility in KO MKs. (F) Cell velocities were measured ± 50 mM of the MEK1
inhibitor PD98059 and ± 5 mM of the Src inhibitor PP2, which also inhibits FAK activity. (C, E, and F) Thirty cells were tracked by phase-contrast mi-
croscopy with an acquisition rate of 1 frame/min over 12 hr. Bar graphs indicate average velocity ± SEM. *p < 0.05. **p < 0.0001. (G) Scatter plots
depict the migration tracks of 5 representative cells for each condition.Hyperactivation of Regulatory Circuitries
Involving Integrin-FAK-Src-MAPK Signaling
and Cell Migration: Links between Loss of TbRII
and Enhanced Wound Healing, SQCC
Progression, and Metastasis
In exploring the underlying basis for why the junction be-
tween simple epithelium of the intestine and squamous324 Cancer Cell 12, 313–327, October 2007 ª2007 Elsevier Incepithelium of the anal canal might be particularly sensitive
to SQCC progression, we began to realize that this transi-
tional epithelium naturally possesses many of the same
features that are displayed by the epidermis when it either
responds to wounding in normal individuals or exists in
patients with hyperproliferative skin disorders (Coulombe,
2003; Weiss et al., 1984). Thus, WT anogenital epithelium.
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Loss of TGFbRII in Stratified Epitheliais not only substantially thicker andmore proliferative than
backskin epidermis, but in addition it expresses hyperpro-
liferative-associated suprabasal keratins as well as migra-
tion-associated integrins and ECM ligands, and even dis-
plays a high number of inflammatory cells in the underlying
stroma. These findings suggest that this zone of stratified
epithelium may be naturally subjected to a chronic hyper-
proliferative state, a trait which renders the epithelium
more susceptible to loss of tissue homeostasis when
TGFb signaling is compromised.
It is particularly intriguing that TnC and b6-integrin are
expressed at this site as their expression is known to
correlate with invasive growth during wound healing and
tumorigenesis (Bates et al., 2005; Munger et al., 1999).
Furthermore, avb6 can activate latent TGFb1 and TGFb3
leading to TGFb stimulation in mice (Annes et al., 2004).
In this way, the activation of avb6/TnC may provide
a mechanism for hyperproliferative epithelial tissues to
keep homeostasis in check by stimulating and responding
to TGFb signaling, a process interrupted by conditionally
targeting TbRII.
Another link between loss of TbRII and altered integrin
activation came from our studies in cultured MKs, which
like anal epithelia, naturally display elevated avb6 sig-
naling (Schober et al., 2007). In the absence of TbRII,
however, cultured MKs additionally displayed higher b1-
integrin, FAK, Src, and MAPK activities, and enhanced
migration and invasion. This was the case even when cells
were cultured in the absence of exogenous growth fac-
tors, suggesting that the mechanism is intrinsic to the
keratinocyte, and is mediated through integrin signaling.
It is also dependent upon TbRII deficiency, as reintroduc-
tion of TbRII expression into TbRII null cells reduced their
migratory behavior to WT levels.
TGFb signaling has been attributed to wound healing
and cell motility, although a variety of Smad-dependent
and independent mechanisms have been implicated, and
both positive and negative effects have been described
(Arany et al., 2006; Ashcroft et al., 1999; Crowe et al.,
2000; Koch et al., 2000; Oft et al., 1998; Zhu et al.,
1998). Our studies provide compelling evidence that loss
of TGFb signaling in keratinocytes promotes wound clo-
sure in vivo and leads to enhanced epidermal outgrowth
from explants in vitro. The advantage of TbRII null epider-
mis in wound healing does not appear to be attributable
solely to the alterations in proliferation and apoptosis, as
the average velocities of migrating TbRII null MKs were
significantly higher than WT MKs even in vitro and in the
absence of active TGFbs, i.e., conditions where prolifera-
tive and apoptotic levels were comparable.
At first glance, our finding might seem paradoxical in
light of those studies where TGFb stimulates cell motility
inMKsor in other cell types. That said, a bi-phasic concen-
tration-dependent response is often observed inmigrating
cells where suboptimal cell velocities have resulted from
either elevated or abrogated chemotactic signaling or ele-
vated or decreased adhesiveness to the underlying sub-
stratum (Lauffenburger and Horwitz, 1996). In this regard,
hyperactivation of b1-integrin-FAK-Src-MAPK signalingCacan profoundly influence cell motility and conversely phar-
macological inhibition of FAK and Src activities strongly
suppressed the migratory advantage of TbRII null MKs.
These data argue for a role for FAK and Src downstream
of TbRII in controlling cell motility in keratinocytes.
The increased activity of b1, FAK, Src, and MAPK activ-
ities coupled with enhanced migratory activity could also
explain why cKO mice repaired their wounds faster than
their WT counterparts. Not only is FAK hyperactive in nor-
mal wound repair, but conversely, conditional ablation of
FAK in keratinocytes impairs epidermal outgrowth from
skin explants in vivo and causes defects in hair follicle
downgrowth in vivo (Mitra et al., 2006; Schober et al.,
2007). Interestingly, FAK deficiency also renders stratified
squamous epithelia resistant to Ha-Ras-induced SQCC
formation (McLean et al., 2004), further strengthening
the importance of the connection between loss of TbRII,
elevated integrin-FAK signaling, and enhanced cell migra-
tion that we’ve uncovered here.
In closing, although future studies will be necessary to
illuminate more of the details underlying the circuitry
we’ve described, our data provide a mechanistic frame-
work for understanding the role of TGFb signaling in regu-
lating homeostasis, injury response, and carcinogenesis
in epithelial tissues, and offer a molecular explanation for
the surface epithelial tumorigenesis that occurs when
TGFb signaling is compromised.
EXPERIMENTAL PROCEDURES
Generation of cKO Mice, Carcinogenesis Protocols,
and Analysis of Tumors
TbRII floxed mice and K14-Cre transgenic mice were generated as
described (Leveen et al., 2002; Vasioukhin et al., 1999). Genotyping
was conducted by PCR of tail skin DNAs. Complete carcinogenesis
protocols were performed on cohorts of 6 WT and 5 cKO mice at 6–
8 weeks of age as described (Harper et al., 1987). Tumor pathologies
were analyzed by at least two independent pathologists in the Labora-
tory of Comparative Pathology at Cornell University Medical College.
All studies were approved by the IACUC committee and follow the
NIH guidelines.
Immunofluorescence, Antibodies, Inhibitors,
and In Situ Hybridization
Primary antibodies are described in the Supplemental Experimental
Procedures. For detection of apoptosis Annexin V (Molecular Probes)
was used. Chemical inhibitors used: PD98059 (MEK, Calbiochem,
50 mM for 6 hr), and PP2 (Src, Calbiochem, 5 mM).
Human Tumor Studies and Anatomic Pathology
Tissue microarray from 118 human skin SQCCs (SK241, SK242,
SK801, SK802) and from 80 male and 41 female genital SQCCs
(UV241, UV801, PE241, PE801) were obtained from US Biomax,
Rockeville, MD. Paraffin slides were deparaffinized and stained with
either TbRII or p-Smad2 antibodies, followed by the DAB substrate
kit for peroxidase visualization of secondary antibodies (Vector Labo-
ratories).
Wound, Explant, and Migration/Invasion Assays
In vivo wounds on 7-week-old animals were performed using a 4 mm
dermal biopsy punch (Miltex). The size of the closing wound was mon-
itored daily until day 8. Skin explants and migration assays were per-
formed as described (Schober et al., 2007). Invasion assays werencer Cell 12, 313–327, October 2007 ª2007 Elsevier Inc. 325
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Loss of TGFbRII in Stratified Epitheliaperformed in precoated Matrigel invasion chamber (BD Biosciences).
Individual MKs were imaged with an Olympus phase-contrast micro-
scope (20X) for 12 hr at 1 frame/min and manually tracked in Meta-
morph (Universal Imaging).
Supplemental Data
The Supplemental Data include Supplemental Experimental Proce-
dures and seven supplemental figures and can be found with this
article online at http://www.cancercell.org/cgi/content/full/12/4/313/
DC1/.
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